Empagliflozin

Dr. McPhee: This is not quite the best option in this case. Empagliflozin can an excellent drug, particularly for patients with certain co-morbidities, such as heart failure, chronic kidney disease, and established or high atherosclerotic cardiovascular (ASCVD) risk. It can also help when weight loss is a goal. There is no compelling cardiorenal indication to start it ahead of another drug that is more cost-effective and could also provide benefits in preventing complications and reducing weight.

Please go back and reconsider.

  • I will independently adjust the dose of warfarin (decrease/increase)This is a wrong response that could lead to potentially harmful results to the health [undo]
  • Nurse's Initial Report [undo]
  • Ζητά επαναληπτική εξέταση PCR [undo]
  • Splash! [undo]
  • Λάθος! [undo]
  • Metformin [undo]
  • Insulin [undo]
  • Root Node [undo]
  • No [undo]
  • Aιτία προσέλευσης [undo]
  • Drugs without diagnosis [undo]
  • [undo]
  • I will start taking the blood-clotting pills and the special herb that helps with bleeding gums, my aunt Maria suggested. [undo]
  • Jeg forklarer foreldrene at jeg tar opp saken med assistenten så fort så mulig [undo]
  • IDENTIFICATION OF BIOMOLECULES [undo]
  • Empagliflozin [undo]

Map: Michael Green_GEMD_1 (1115)
Node: 21088
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway